Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sclerotherapy with Polidocanol Foam for Second-degree Hemorrhoids
NCT03791775Phase 2Completed
- Sponsor
- Società Italiana di Chirurgia ColoRettale
- Start
- Jan 2019
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of 10XB101 in hemorrhoidal disease, sponsored by Società Italiana di Chirurgia ColoRettale. Primary endpoint: Success Rate 1 at 12 months. Started Jan 2019; status: completed.
02
Drugs
10XB101
03
Conditions
hemorrhoidal disease
Beyond the preview
Go deeper on NCT03791775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03791775.